United States Bone Cancer Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Global Bone Cancer Treatment Market is growing with a high CAGR during the forecast period 2024-2031.

Key Development:

United States: Recent Industry Developments

✅ September 18, 2025 - In September, Break Through Cancer launched the largest-ever investment in pediatric osteosarcoma research, mobilizing a $15 million initiative with eight leading research institutions and over 20 researchers. This effort aims to accelerate advancements in treatment for this rare bone cancer.

✅ July 31, 2025 - In July, Terry Fox Foundation-funded research offered new hope for patients with osteosarcoma, a rare bone cancer that Terry Fox had. This collaborative effort aims to improve treatments and outcomes for patients with this challenging condition.

✅ July 7, 2025 - In July, charities including the Bone Cancer Research Trust and Great Ormond Street Hospital Charity co-funded a groundbreaking £800,000 project to improve treatments for Ewing sarcoma, a rare bone cancer affecting children and young adults.

Japan: Recent Industry Developments

✅ July 30, 2025 - In July, DelveInsight's analysis projected the osteosarcoma market in Japan to grow significantly by 2034, indicating a positive trend in the development and availability of treatments for this rare bone cancer.

✅ July 7, 2025 - In July, Japanese charities, including the Bone Cancer Research Trust and the Ewing's Sarcoma Research Trust, announced a record £800,000 investment focused on improving treatments for Ewing sarcoma patients, marking a significant milestone in their commitment to bone cancer patients.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/bone-cancer-market?sb

Bone cancer is a malignant tumor that originates in bone tissue, either as a primary cancer (e.g., osteosarcoma, Ewing's sarcoma) or secondary due to metastasis from other organs. It can cause pain, fractures, and swelling, and is managed through surgery, chemotherapy, radiotherapy, or targeted therapies depending on the type and stage.

Recent Mergers and acquisitions:

United States: Recent M&A Developments in Bone Cancer

✅ July 2025 - In July, Johnson & Johnson acquired Intra-Cellular Therapies for $14.6 billion, enhancing its oncology portfolio with treatments targeting central nervous system disorders.

✅ June 2025 - In June, Sanofi announced the acquisition of Blueprint Medicines, expanding its portfolio in rare immunological diseases and adding an early-stage pipeline in immunology.

✅ March 2025 - In March, AstraZeneca acquired Belgian biotech EsoBiotec for up to $1 billion, focusing on in-vivo CAR-T cell therapies designed to empower the immune system to attack cancer.

Japan: Recent M&A Developments in Bone Cancer

✅ October 2025 - In October, Takeda Pharmaceutical announced its decision to discontinue cell therapy initiatives and seek a partner to further develop its research and clinic-ready programs in this area.

✅ July 2025 - In July, Genmab, a Danish biotech company, acquired a Dutch oncology firm for $8 billion, strengthening its position in the cancer treatment market.

Key Players:

=> Pfizer Inc., MicroBiopharm Japan Co. Ltd., Sterling Biotech Ltd., Teva Pharmaceuticals Industries Ltd., Cipla Ltd., Aspen API Inc., Eli Lilly and Company, Gatewell Oncology Pvt. Ltd., Recordati Rare Diseases Inc., Novartis AG among others.

Growth Forecast Projected:

The Global Bone Cancer Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Bone Cancer Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=bone-cancer-market

Key Segments:

➥ By Type: Primary Bone Cancer, Secondary Bone Cancer
➥ By Treatment: Chemotherapy, Targeted Therapy, Radiation Therapy, Cryosurgery, Others
➥ By End User: Hospitals, Clinics, Cancer Centers, Others

Regional Analysis for Bone Cancer Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Bone Cancer producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Bone Cancer revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bone-cancer-market?sb

FAQ

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.